AVKARE Inc. has recalled 5,953 bottles of Fexofenadine Hydrochloride (generic Allegra) Tablets USP Antihistamine 180 mg because the product failed stability specifications during testing. This means the medication may not maintain its effectiveness or quality through its listed expiration date. This recall affects the 500-count bottles distributed nationwide. Consumers should consult their healthcare provider or pharmacist regarding the continued use of this medication.
The failure to meet stability specifications indicates the drug may lose potency or chemical integrity before the expiration date, potentially resulting in reduced effectiveness for treating allergy symptoms. While no injuries have been reported, the medication may not provide the intended relief for consumers.
Drug recall baseline remedy
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.